Log in to save to my catalogue

Developments in the management of autosomal dominant polycystic kidney disease

Developments in the management of autosomal dominant polycystic kidney disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2504069

Developments in the management of autosomal dominant polycystic kidney disease

About this item

Full title

Developments in the management of autosomal dominant polycystic kidney disease

Publisher

New Zealand: Taylor & Francis Ltd

Journal title

Therapeutics and clinical risk management, 2008-04, Vol.4 (2), p.393-407

Language

English

Formats

Publication information

Publisher

New Zealand: Taylor & Francis Ltd

More information

Scope and Contents

Contents

Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent life- threatening, hereditary disease. ADPKD is more common than sickle cell anemia, cystic fibrosis, muscular dystrophy, hemophilia, Down's syndrome, and Huntington's disease combined. ADPKD is a multisystemic disorder characterized by the progressive development of renal cy...

Alternative Titles

Full title

Developments in the management of autosomal dominant polycystic kidney disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2504069

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2504069

Other Identifiers

ISSN

1176-6336,1178-203X

E-ISSN

1178-203X

DOI

10.2147/TCRM.S1617

How to access this item